Skip to main content

Table 1 Description of study cohort

From: Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome

Clinical and serological manifestations

APS patients (n = 130)

All controls (n = 58)

Healthy controls N = 40

Sepsis control n = 18

Age (years ± SD)

43.8 ± 13.2

37.7 ± 10.7

37 ± 11.7

39 ± 9

Gender (Female)

79.2%

66%

80%

30%

Time from diagnosis (years ± SD)

8.3 ± 7.4

NA

  

Secondary APS

51.5%

NA

  

Arterial thrombosis

47.7%

NA

  

CNS manifestations

35.4%

NA

  

Venous thrombosis

59.2%

NA

  

Pregnancy morbidity

29.2%

NA

  

(LAC) positivity

84.0%

NA

  

Triple positive (aCL + aβ2GP1 + LAC)

55.0%

NA

  
  1. Data retrieved from medical files
  2. APS antiphospholipid antibody syndrome, CNS central nervous system, NA not applicable, aCL antibody to cardiolipin, aβ2GP1 antibody to beta2-glycoprotein1, LAC lupus anticoagulant